Abbott Laboratories (ABT) Interest & Investment Income (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Interest & Investment Income data on file, last reported at $106.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income rose 29.27% year-over-year to $106.0 million; the trailing twelve-month figure through Mar 2026 stood at $332.0 million (down 4.05% YoY), and the FY2025 full-year result was $308.0 million, down 49.59% from the prior year.
• Interest & Investment Income improved to $106.0 million in Q1 2026, from $78.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $106.0 million in Q1 2026 to a low of $14.0 million in Q1 2022.
• A 5-year average of $78.0 million and a median of $82.0 million in 2024 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income jumped 700.0% in 2022 and dropped 20.79% in 2024, its largest moves.
• Tracing ABT's Interest & Investment Income over 5 years: stood at $88.0 million in 2022, then increased by 1.14% to $89.0 million in 2023, then gained by 2.25% to $91.0 million in 2024, then declined by 14.29% to $78.0 million in 2025, then soared by 35.9% to $106.0 million in 2026.
• Business Quant data shows ABT's Interest & Investment Income at $106.0 million in Q1 2026, $78.0 million in Q4 2025, and $77.0 million in Q3 2025.